Compare
Avai Bio, Inc. vs KwikClick, Inc. vs StageWise Strategies Corp. vs Readvantage Corp.
| Latest fiscal year | Avai Bio, Inc. AVAI | KwikClick, Inc. KWIK | StageWise Strategies Corp. STWI | Readvantage Corp. RADC |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2026-06-30 |
| Revenue | n/a | $1.29M | $95.4K | $47.8K |
| Revenue growth (YoY) | n/a | +718.1% | +959.3% | +268.4% |
| Gross margin | n/a | n/a | 100.0% | n/a |
| Operating margin | n/a | -93.2% | -78.4% | -222.7% |
| Net margin | n/a | -102.3% | -78.4% | -222.7% |
| Net income | -$1.75M | -$1.32M | -$74.8K | -$106.4K |
| EPS (Diluted) | n/a | -$0.34 | -$0.02 | n/a |
| Operating cash flow | -$1.01M | -$202.1K | -$48.5K | -$89.6K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $23.1K | $106.5K | $4.6K | n/a |
| Total assets | $572.7K | $868.8K | $164.9K | $97.3K |
| Total liabilities | $3.39M | $4.08M | $241.9K | $229.9K |
| Shareholders' equity | -$2.82M | -$3.21M | -$77.0K | -$132.6K |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | 153.21M | 3.89M | 5.04M | 6.95M |
Revenue, most recent five fiscal years
| Fiscal year | Avai Bio, Inc. | KwikClick, Inc. | StageWise Strategies Corp. | Readvantage Corp. |
|---|---|---|---|---|
| Latest | $276.3K Ended 2023-03-31 | $1.29M Ended 2025-12-31 | $95.4K Ended 2025-09-30 | $47.8K Ended 2026-06-30 |
| 1 year earlier | n/a | $157.4K Ended 2024-12-31 | $9.0K Ended 2024-09-30 | $13.0K Ended 2025-06-30 |
| 2 years earlier | n/a | $288.2K Ended 2023-12-31 | n/a | n/a |
| 3 years earlier | n/a | $606.8K Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $175.6K Ended 2021-12-31 | n/a | n/a |